Myocholine (Bethanechol Chloride)

Bethanechol Chloride, the active ingredient in Myocholine, is a cholinergic agonist (parasympathomimetic) presented as an oral formulation for oral use. It is employed to stimulate smooth‑muscle contraction in the urinary and gastrointestinal tracts, helping to relieve postoperative urinary retention and postoperative ileus in adult patients.

GNH USA supplies Myocholine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, surgical centres and clinics worldwide.

Myocholine (bethanechol chloride) acts on muscarinic receptors to promote smooth‑muscle activity in the urinary and gastrointestinal systems. It is indicated for the following conditions:

- Postoperative urinary retention: facilitates bladder emptying by increasing detrusor muscle tone. - Neurogenic bladder: improves urinary flow in patients with impaired bladder innervation. - Postoperative ileus: accelerates return of intestinal motility after abdominal surgery.

Adverse reactions may occur with Myocholine and are categorized by frequency.

Common Side Effects: - Abdominal cramps: discomfort due to increased intestinal activity. - Diarrhea: loose stools resulting from enhanced gut motility. - Sweating: excessive perspiration caused by cholinergic stimulation. - Flushing: redness of the skin, especially on the face and neck. - Increased salivation: excess saliva production. - Nausea: feeling of queasiness.

Serious or Rare Side Effects: - Bronchospasm: narrowing of the airways that can cause breathing difficulty. - Severe hypotension: marked drop in blood pressure leading to dizziness or fainting. - Bradycardia: unusually slow heart rate. - Seizures: convulsive episodes in susceptible individuals. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Urinary retention paradox: worsening of bladder emptying in rare cases.

Before prescribing Myocholine, clinicians should consider several safety measures.

- Assess renal function: dose may need adjustment in impaired kidneys. - Monitor cardiovascular status: watch for hypotension or bradycardia. - Avoid use in patients with asthma or chronic obstructive pulmonary disease: risk of bronchospasm. - Use caution in the elderly: increased sensitivity to cholinergic effects. - Review concomitant anticholinergic therapy: may diminish efficacy. - Store at ambient temperature: keep below 25°C, in the original container, protected from moisture and light.

Myocholine can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Anticholinergic agents (e.g., atropine, ipratropium): block muscarinic receptors and negate therapeutic effect. - General anesthetics that depress respiration (e.g., succinylcholine): may increase risk of respiratory complications.

Moderate Interactions (Monitor Closely): - Macrolide antibiotics (e.g., erythromycin): may increase cholinergic activity. - Opioid analgesics: additive constipation may mask gastrointestinal effects. - Diuretics: combined hypotensive effect may require blood pressure monitoring. - Beta‑blockers: potential additive bradycardia. - Antihypertensive agents: may enhance blood pressure lowering.